Bani Tamraz, PharmD, PhD, is the featured Pharmacogenomics Research Network Investigator (PGRN) for February 2019. An article on the group’s website described his overall goal to build a patient-oriented program of pharmacogenetics research, teaching, and clinical practice that utilizes genetics for therapy optimization at UCSF and beyond. He was a featured speaker ar PGRN in February, 2020.

PGRN article

Featured PGRN Investigator

Dr. Tamraz is an Assistant Professor in the Department of Clinical Pharmacy at UCSF School of Pharmacy. His overall goal is to build a patient-oriented program of pharmacogenetics (PGx) research, teaching and clinical practice that utilizes genetics for therapy optimization at UCSF and beyond. To this end, he is leading projects with an overarching vision of creating the UCSF Health-School of Pharmacy PGx clinical service. As part of this effort, he is in the last phase of CLIA validation of a gene panel for clinical PGx testing at UCSF Health, is leading cost-effectiveness analyses and planning and developing a clinical decision support (CDS) structure for delivering the PGx recommendations from lab to frontline clinicians. In addition to application of PGx, Dr. Tamraz is engaged in numerous PGx studies in the areas of HIV, pediatric bone marrow transplant, ophthalmology and in vitro fertilization. He recently published a genome wide association study of atazanavir exposure measured in hair of women in the Women’s Interagency HIV Study (WIHS) cohort that identified a SNP in SORCS2 associated with decreased exposure.